Mirum Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MIRM and other ETFs, options, and stocks.About MIRM
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.
CEOChristopher Peetz
CEOChristopher Peetz
Employees322
Employees322
HeadquartersFoster City, California
HeadquartersFoster City, California
Founded2018
Founded2018
Employees322
Employees322
MIRM Key Statistics
Market cap3.68B
Market cap3.68B
Price-Earnings ratio-83.00
Price-Earnings ratio-83.00
Dividend yield—
Dividend yield—
Average volume482.67K
Average volume482.67K
High today$71.98
High today$71.98
Low today$69.86
Low today$69.86
Open price$70.72
Open price$70.72
Volume227.45K
Volume227.45K
52 Week high$78.54
52 Week high$78.54
52 Week low$36.88
52 Week low$36.88
Stock Snapshot
The current Mirum Pharmaceuticals(MIRM) stock price is $71.53, with a market capitalization of 3.68B. The stock trades at a price-to-earnings (P/E) ratio of -83.00.
On 2025-12-04, Mirum Pharmaceuticals(MIRM) stock traded between a low of $69.86 and a high of $71.98. Shares are currently priced at $71.53, which is +2.4% above the low and -0.6% below the high.
The Mirum Pharmaceuticals(MIRM)'s current trading volume is 227.45K, compared to an average daily volume of 482.67K.
In the last year, Mirum Pharmaceuticals(MIRM) shares hit a 52-week high of $78.54 and a 52-week low of $36.88.
In the last year, Mirum Pharmaceuticals(MIRM) shares hit a 52-week high of $78.54 and a 52-week low of $36.88.
Analyst ratings
100%
of 10 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own MIRM. This list is generated using Robinhood data, and it’s not a recommendation.